BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 3537362)

  • 1. [Current status of adjuvant chemotherapy of gastric cancer].
    Nakajima T; Nishi M
    Gan No Rinsho; 1986 Aug; 32(10):1219-22. PubMed ID: 3537362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant chemotherapy for gastric cancer in Japan: present status and suggestions for rational clinical trials.
    Nakajima T
    Jpn J Clin Oncol; 1990 Mar; 20(1):30-42. PubMed ID: 2181170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Issues of adjuvant chemotherapy in gastric cancer: its clinical significance].
    Nakajima T
    Gan To Kagaku Ryoho; 1991 May; 18(6):952-7. PubMed ID: 2029198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Meta-analysis of 10 postoperative adjuvant chemotherapies for gastric cancer in CIH].
    Nakajima T; Ota K; Ishihara S; Oyama S; Nishi M; Hamashima N
    Gan To Kagaku Ryoho; 1994 Aug; 21(11):1800-5. PubMed ID: 8080299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative chemotherapy for gastric cancer.
    Hejna M; Wöhrer S; Schmidinger M; Raderer M
    Oncologist; 2006 Feb; 11(2):136-45. PubMed ID: 16476834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Overview of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
    Sasako M; Sano T; Katai H; Okajima K; Maruyama K
    Gan To Kagaku Ryoho; 1994 Oct; 21 Suppl 3():384-94. PubMed ID: 7986119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of adjuvant therapy for resected primary gastric cancer with an update on Taegu's phase III trial with intraperitoneal chemotherapy.
    Yu W
    Eur J Surg Oncol; 2006 Aug; 32(6):655-60. PubMed ID: 16618532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Efficacy of current adjuvant and neoadjuvant therapeutic concepts in gastric cancer?].
    Kretzschmar A; Schlag PM
    Zentralbl Chir; 2006 Apr; 131(2):121-5. PubMed ID: 16612778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of clinical trials on adjuvant chemotherapy for curatively resected gastric cancer].
    Kitamura M; Arai K; Iwasaki Y
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1221-9. PubMed ID: 9279340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current status and problem of adjuvant chemotherapy for curatively resected gastric cancer].
    Saka M; Sasako M; Katai H; Sano T
    Gan To Kagaku Ryoho; 2000 Nov; 27(13):2033-42. PubMed ID: 11103234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selecting a specific pre- or postoperative adjuvant therapy for individual patients with operable gastric cancer.
    Briasoulis E; Liakakos T; Dova L; Fatouros M; Tsekeris P; Roukos DH; Kappas AM
    Expert Rev Anticancer Ther; 2006 Jun; 6(6):931-9. PubMed ID: 16761937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upper abdominal stop-flow perfusion as a neo and adjuvant hypoxic regional chemotherapy for resectable gastric carcinoma. A prospective randomized clinical trial.
    Lygidakis NJ; Sgourakis G; Aphinives P
    Hepatogastroenterology; 1999; 46(27):2035-8. PubMed ID: 10430393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The current status of postoperative adjuvant chemotherapy for colorectal cancer].
    Kodaira S
    Gan To Kagaku Ryoho; 1997 Aug; 24(10):1230-8. PubMed ID: 9279341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of adjuvant chemotherapy after radical surgery for advanced gastric cancer.
    Sun P; Xiang JB; Chen ZY
    Br J Surg; 2009 Jan; 96(1):26-33. PubMed ID: 19016271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overview of adjuvant therapy for resected gastric cancer: differences in Japan and the United States.
    Ohtsu A; Sasako M
    Semin Oncol; 2005 Dec; 32(6 Suppl 9):S101-4. PubMed ID: 16399444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Progress in postoperative adjuvant chemotherapy in gastric cancer].
    Nakajima T; Ohta K; Ohyama S; Yamaguchi T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2481-7. PubMed ID: 12506470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stomach carcinoma. Optimizing therapy by neoadjuvant or adjuvant therapy?].
    Rosen H
    Zentralbl Chir; 1999; 124(5):387-93. PubMed ID: 10420523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.
    Nashimoto A; Nakajima T; Furukawa H; Kitamura M; Kinoshita T; Yamamura Y; Sasako M; Kunii Y; Motohashi H; Yamamoto S;
    J Clin Oncol; 2003 Jun; 21(12):2282-7. PubMed ID: 12805327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New insights in the adjuvant treatment of gastric cancer].
    Jansen EP; Boot H; Cats A; van Coevorden F; Zoetmulder FA; Verheij M
    Ned Tijdschr Geneeskd; 2004 Dec; 148(51):2529-34. PubMed ID: 15636473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.